We have detected that you are using Internet Explorer or Microsoft Edge Legacy. Please consider upgrading your browser to any of the following for the best experience.
PreventionGenetics Receives FDA Approval for its Companion Diagnostic Genetic Test as a Class II Medical Device
Published on
PreventionGenetics, a subsidiary of Exact Sciences Corp., announced today that it was recently granted marketing authorization for the POMC/PCSK1/LEPR companion diagnostic (CDx) genetic test as a Class II device by the Center for Devices and Radiological Health (CDRH), a division of the Food and Drug Administration (FDA). Developed in collaboration with Rhythm Pharmaceuticals, Inc., the test is the first FDA-authorized Class II molecular companion diagnostic device.
We recently released an option for our pre-defined panels to be run on a PGnome® (genome) sequencing backbone. But you may be wondering … what’s a backbone?
PreventionGenetics will not be receiving samples Monday, September 5 in observance of Labor Day. We request that you take this into consideration when shipping cell cultures and time-sensitive specimens. Our regular shipping and receiving instructions apply to all other days over this holiday weekend.
The last thing many people want to think about is their own mortality, which often leaves their families to deal with funeral planning, expenses and, sometimes, unresolved medical decisions. They turn to you as a resource in their time of grief. As a funeral director, your interaction with families during a time of loss is their last opportunity to preserve a loved one’s DNA.
Inherited kidney diseases have an overall prevalence of ~6-8 in 10,000 births in the United States and Europe, and accounts for up to 37% of adults with renal diseases (Cocchi et al. 2020. PubMed ID: 32646915; Connaughton et al. 2019. PubMed ID: 30773290; Lata et al. 2018. PubMed ID: 29204651). Obtaining an early diagnosis for kidney disease is important for establishing optimal maintenance and treatment plans for patients and their families, which is why genetic testing has been increasingly integrated into clinical practice.
We use cookies and tracking to improve your browsing experience on our website, to analyze our website traffic, and to understand where our visitors are coming from. By browsing our website, you consent to this.
